L

Lightchain

Description

Lightchain is a non-profit organization that specializes in Information technology software & the internet.

Investor Profile

Lightchain has made 10 investments, with 0 in the past 12 months and 30% as lead.

Stage Focus

  • Series B (40%)
  • Series Unknown (30%)
  • Series A (10%)
  • Series C (10%)
  • Series D (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Therapeutics
  • Medical
  • Health Care
  • Cloud Data Services
  • Enterprise Software
  • Saas
  • Voip
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lightchain frequently co-invest with?

3×5 Partners
North America, Oregon, United States, Portland
Co-Investments: 2
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Cobro Ventures
North America, Virginia, United States, Arlington
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 6
3E Bioventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Axil Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 3
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Allos Ventures
North America, Indiana, United States, Carmel
Co-Investments: 2

Which angels does Lightchain often collaborate with?

Shared Deals: 1

What are some of recent deals done by Lightchain?

Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BNov 16, 2021
Amount Raised: $105,000,000
Wugen

St Louis, Missouri, United States

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

BiotechnologyTherapeutics
Series BJul 15, 2021
Amount Raised: $172,000,000
Arch Oncology

St Louis, Missouri, United States

Arch Oncology is a venture-stage biopharmaceutical company.

BiotechnologyMedicalOncologyTherapeutics
Series CApr 27, 2021
Amount Raised: $105,000,000
SharpenCX

Indianapolis, Indiana, United States

Sharpen is an agent-first omnichannel cloud contact center platform that offers voice and software solutions.

Cloud Data ServicesEnterprise SoftwareSaaSVoIP
Series UnknownSep 9, 2020
Amount Raised: $12,000,000
C4 Therapeutics

Cambridge, Massachusetts, United States

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Health DiagnosticsMedicalTherapeutics
Series BJun 16, 2020
Adarza BioSystems

St Louis, Missouri, United States

Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.

BiotechnologyClinical TrialsHealth CareHealth Diagnostics
Series DFeb 4, 2020
Amount Raised: $25,000,000
Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series AOct 2, 2019
Amount Raised: $6,900,000
FinTech Studios

New York, New York, United States

AI-based market intelligence and regulatory intelligence platform for Wall Street

AnalyticsArtificial Intelligence (AI)Big DataFinancial ServicesFinTechMachine LearningMobile AppsNatural Language ProcessingSoftware
Series UnknownSep 16, 2019
Amount Raised: $5,100,000
Arch Oncology

St Louis, Missouri, United States

Arch Oncology is a venture-stage biopharmaceutical company.

BiotechnologyMedicalOncologyTherapeutics
Series BMar 25, 2019
Amount Raised: $50,000,000
SharpenCX

Indianapolis, Indiana, United States

Sharpen is an agent-first omnichannel cloud contact center platform that offers voice and software solutions.

Cloud Data ServicesEnterprise SoftwareSaaSVoIP
Series UnknownMar 12, 2019
Amount Raised: $15,000,000